Study: Rituxan Reduces Disease Activity in EGPA, But Relapses Stay High – ANCA Vasculitis News

Study: Rituxan Reduces Disease Activity in EGPA, But Relapses Stay High – ANCA Vasculitis News

Study: Rituxan Reduces Disease Activity in EGPA, But Relapses Stay High – ANCA Vasculitis News
Published on 2019-06-24